181 related articles for article (PubMed ID: 36323529)
21. A 7-gene signature predicts the prognosis of patients with bladder cancer.
Tang F; Li Z; Lai Y; Lu Z; Lei H; He C; He Z
BMC Urol; 2022 Jan; 22(1):8. PubMed ID: 35090432
[TBL] [Abstract][Full Text] [Related]
22. Construction and Validation of an Autophagy-Related Prognostic Signature and a Nomogram for Bladder Cancer.
Yan X; Wu HH; Chen Z; Du GW; Bai XJ; Tuoheti K; Liu TZ
Front Oncol; 2021; 11():632387. PubMed ID: 34221960
[TBL] [Abstract][Full Text] [Related]
23. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer.
Zhang Z; Fang T; Lv Y
Front Genet; 2022; 13():934830. PubMed ID: 36171887
[No Abstract] [Full Text] [Related]
24. Prediction of Overall Survival Among Female Patients With Breast Cancer Using a Prognostic Signature Based on 8 DNA Repair-Related Genes.
Zhang D; Yang S; Li Y; Yao J; Ruan J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Lyu J; Dai Z
JAMA Netw Open; 2020 Oct; 3(10):e2014622. PubMed ID: 33017027
[TBL] [Abstract][Full Text] [Related]
25. Construction and validation of an aging-related gene signature predicting the prognosis of pancreatic cancer.
Wang D; Zhang Y; Wang X; Zhang L; Xu S
Front Genet; 2023; 14():1022265. PubMed ID: 36741321
[No Abstract] [Full Text] [Related]
26. Comprehensive analysis of autophagy-related prognostic genes in breast cancer.
Lai J; Chen B; Mok H; Zhang G; Ren C; Liao N
J Cell Mol Med; 2020 Aug; 24(16):9145-9153. PubMed ID: 32618109
[TBL] [Abstract][Full Text] [Related]
27. Characterization of protein-based risk signature to predict prognosis and evaluate the tumor immune environment in breast cancer.
Qing X; Yuan C; Wang K
Breast Cancer; 2023 May; 30(3):424-435. PubMed ID: 36732487
[TBL] [Abstract][Full Text] [Related]
28. Construction of a prognostic risk assessment model for HER2 + breast cancer based on autophagy-related genes.
Wang F; Fang L; Fu B; Fan C
Breast Cancer; 2023 May; 30(3):478-488. PubMed ID: 36856932
[TBL] [Abstract][Full Text] [Related]
29. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
[TBL] [Abstract][Full Text] [Related]
30. The metabolism-related lncRNA signature predicts the prognosis of breast cancer patients.
Ge X; Lei S; Wang P; Wang W; Wang W
Sci Rep; 2024 Feb; 14(1):3500. PubMed ID: 38347041
[TBL] [Abstract][Full Text] [Related]
31. Identification of the prognostic value of ferroptosis-related gene signature in breast cancer patients.
Wang D; Wei G; Ma J; Cheng S; Jia L; Song X; Zhang M; Ju M; Wang L; Zhao L; Xin S
BMC Cancer; 2021 May; 21(1):645. PubMed ID: 34059009
[TBL] [Abstract][Full Text] [Related]
32. A novel circadian cycle-related gene signature for prognosis prediction of patients with breast cancer.
Hu Y; Fan S; Zhu Y; Xie X
Medicine (Baltimore); 2023 May; 102(18):e33718. PubMed ID: 37144994
[TBL] [Abstract][Full Text] [Related]
33. Construction and validation of a novel aging-related gene signature and prognostic nomogram for predicting the overall survival in ovarian cancer.
Liu L; Zhao J; Du X; Zhao Y; Zou C; Zhou H; Li W; Yan X
Cancer Med; 2021 Dec; 10(24):9097-9114. PubMed ID: 34825509
[TBL] [Abstract][Full Text] [Related]
34. A novel signature of aging-related genes associated with lymphatic metastasis for survival prediction in patients with bladder cancer.
Zhu Z; Li X; Liu D; Li Z
Front Oncol; 2023; 13():1140891. PubMed ID: 37441420
[TBL] [Abstract][Full Text] [Related]
35. A signature based on anoikis-related genes for the evaluation of prognosis, immunoinfiltration, mutation, and therapeutic response in ovarian cancer.
Duan Y; Xu X
Front Endocrinol (Lausanne); 2023; 14():1193622. PubMed ID: 37383389
[TBL] [Abstract][Full Text] [Related]
36. Identification of disulfidptosis-related subtypes, characterization of tumor microenvironment infiltration, and development of a prognosis model in breast cancer.
Liang J; Wang X; Yang J; Sun P; Sun J; Cheng S; Liu J; Ren Z; Ren M
Front Immunol; 2023; 14():1198826. PubMed ID: 38035071
[TBL] [Abstract][Full Text] [Related]
37. A Novel Inflammatory Response-Related Gene Signature Predicts Immune Status and Prognosis of Breast Cancer.
Zhao R; Xie C; Gong Y; Wei S; Yuan M; Gan J; Chen W
J Oncol; 2022; 2022():5468858. PubMed ID: 36467500
[TBL] [Abstract][Full Text] [Related]
38. Bioinformatics identification and validation of aging‑related molecular subtype and prognostic signature in breast cancer.
Li J; Gao F; Su J; Pan T
Medicine (Baltimore); 2023 May; 102(19):e33605. PubMed ID: 37171324
[TBL] [Abstract][Full Text] [Related]
39. Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer.
He M; Hu C; Deng J; Ji H; Tian W
World J Surg Oncol; 2021 Oct; 19(1):294. PubMed ID: 34600547
[TBL] [Abstract][Full Text] [Related]
40. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]